Literature DB >> 22339973

[Chinese guidelines for the diagnosis and treatment of relapsed and refractory acute myelogenous leukemia].

Jie Jin1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22339973

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  2 in total

1.  Blastic plasmacytoid dendritic cell neoplasm with leukemic manifestation and ETV6 gene rearrangement: A case report.

Authors:  N A Gao; Xue-Xia Wang; Jian-Rong Sun; Wen-Zheng Yu; Nong-Jian Guo
Journal:  Exp Ther Med       Date:  2015-01-29       Impact factor: 2.447

2.  Low-dose hypomethylating agent decitabine in combination with aclacinomycin and cytarabine achieves a better outcome than standard FLAG chemotherapy in refractory/relapsed acute myeloid leukemia patients with poor-risk cytogenetics and mutations.

Authors:  Limin Li; Xiaoqian Zhang; Hongjuan Yu; Mingwen Zhang; Mengyuan Xu; Jie Liu; Yueyue Fu; Hongbin Meng; Chengfang Lyu; Xiaoxia Li; Jin Zhou
Journal:  Onco Targets Ther       Date:  2018-10-12       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.